Related Experiment Videos
Not-so-silent infarcts
1Department of Neurological and Psychiatric Sciences, University of Florence, Viale Morgagni 85, 50134, Florence, Italy. pantoni@neuro.unifi.it
The Lancet. Neurology
|July 10, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.
International journal of stroke : official journal of the International Stroke Society·2026
Same author
Recognizing, managing, and preventing cognitive sequelae after stroke. A narrative review.
Cerebral circulation - cognition and behavior·2026
Same author
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.
JAMA network open·2026
Same author
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.
Neurology·2026
Same author
Global burden of cerebral small vessel disease determined from large MRI studies: A systematic review and meta-analysis.
International journal of stroke : official journal of the International Stroke Society·2026
Same author
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis.
Journal of the American Heart Association·2026
Same journal
Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
The Lancet. Neurology·2026
Same journal
UCL Queen Square Institute of Neurology: 75 years of innovation.
The Lancet. Neurology·2026
Same journal
Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
The Lancet. Neurology·2026